Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 03, 2021

SELL
$132.81 - $182.18 $6.1 Million - $8.36 Million
-45,894 Closed
0 $0
Q4 2020

Feb 09, 2021

SELL
$138.17 - $184.34 $270,260 - $360,569
-1,956 Reduced 4.09%
45,894 $7.94 Million
Q3 2020

Nov 04, 2020

BUY
$114.09 - $145.51 $876,097 - $1.12 Million
7,679 Added 19.12%
47,850 $6.67 Million
Q2 2020

Aug 07, 2020

BUY
$89.45 - $129.85 $308,065 - $447,203
3,444 Added 9.38%
40,171 $4.8 Million
Q1 2020

May 08, 2020

BUY
$70.23 - $144.31 $2.58 Million - $5.3 Million
36,727 New
36,727 $3.67 Million

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $160M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Great Lakes Advisors, LLC Portfolio

Follow Great Lakes Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Lakes Advisors, LLC with notifications on news.